Latest debt-to-equity ratio
Vir Biotechnology Debt-to-equity ratio
Direct answer
Vir Biotechnology's debt-to-equity ratio is 9.49%.
The verified market snapshot reports 9.49%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 12, 2026.
Get free Vir Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 9.49%
Explore related company data
View Vir Biotechnology's market capitalizationView Vir Biotechnology's price-to-book ratioView Vir Biotechnology's return on equityView Vir Biotechnology's dividend yieldView Vir Biotechnology's 52-week price rangeView Vir Biotechnology's revenue growthView Vir Biotechnology's profit marginView all Vir Biotechnology key metricsReturn to Vir Biotechnology profile